(-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Chemico-Biological Interactions

• Publication date

  2010-05-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cbi.2010.03.036PMID 20346928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

  2010cited by this paper
• Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells

  2009cited by this paper
• (–)‐Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor–vascular endothelial growth factor receptor axis

  2009cited by this paper
• Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

  2009cited by this paper
• (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R.

  2009cited by this paper
• Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study

  2008cited by this paper
• Systemic treatment of colorectal cancer.

  2008cited by this paper
• (−)-Epigallocatechin Gallate Suppresses Azoxymethane-Induced Colonic Premalignant Lesions in Male C57BL/KsJ-db/db Mice

  2008cited by this paper
• VEGF-targeted therapy: mechanisms of anti-tumour activity

  2008cited by this paper
• EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells.

  2008cited by this paper
• Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal Cancer

  2007cited by this paper
• Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells

  2006cited by this paper
• Green tea catechin, epigallocatechin‐3‐gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex

  2006cited by this paper
• Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells.

  2006cited by this paper
• EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.

  2005cited by this paper
• (−)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells

  2005cited by this paper
• EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.

  2005cited by this paper
• Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1.

  2003cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation.

  2002cited by this paper
• Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells*

  2002cited by this paper
• Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.

  2002cited by this paper
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression

  2001cited by this paper
• Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

  2001cited by this paper
• EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells

  2001cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

  2000cited by this paper
• Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.

  2000cited by this paper
• Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.

  1999cited by this paper
• Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

  1999cited by this paper
• Inhibition of carcinogenesis by tea.

  1997cited by this paper
• Inhibition of carcinogenesis by tea

  1997cited by this paper
• Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols.

  1991cited by this paper

• Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer

  2025cites this paper
• Angiogenesis as a Therapeutic Target of (Poly)phenols: Tackling Cancer and Vascular‐Related Complications

  2025cites this paper
• Flavonoids with Anti-Angiogenesis Function in Cancer

  2024cites this paper
• Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets

  2024cites this paper
• Modulation of long noncoding RNAs by polyphenols as a novel potential therapeutic approach in lung cancer: A comprehensive review

  2024cites this paper
• Medicinal chemistry insights into PRMT5 inhibitors.

  2024cites this paper
• Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects.

  2024cites this paper
• Causal associations of tea consumption on risk of pancreatic adenocarcinoma and the mediating role of vascular endothelial growth factor D levels

  2024cites this paper
• Targeting Tumor Endothelial Cells by EGCG Using Specific Liposome Delivery System Inhibits Vascular Inflammation and Thrombosis

  2024cites this paper
• Molecular mechanisms underlying the epigallocatechin-3-gallate-mediated inhibition of oral squamous cell carcinogenesis.

  2023cites this paper
• Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies

  2023cites this paper
• Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer.

  2023cites this paper
• Anticancer Therapeutic Effects of Green Tea Catechins (GTCs) When Integrated with Antioxidant Natural Components

  2023cites this paper
• Tannins in cancer prevention and therapy

  2023cites this paper
• Modern aspects of the use of natural polyphenols in tumor prevention and therapy

  2022cites this paper
• Vascular Endothelial Growth Factor Receptors [VEGFR] as Target in Breast Cancer Treatment: Current Status in Preclinical and Clinical Studies and Future Directions.

  2022cites this paper
• Chemico-biological aspects of (−)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects

  2022cites this paper
• MSOT-Guided Nanotheranostics for Synergistic Mild Photothermal Therapy and Chemotherapy to Boost Necroptosis/Apoptosis.

  2022cites this paper
• Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy

  2022cites this paper
• Plants as a Source of Anticancer Agents: From Bench to Bedside

  2022cites this paper
• Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: Structure-activity relationship and mechanism of action.

  2022cites this paper
• Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis

  2022cites this paper
• Validation of antioxidant, antiproliferative, and in vitro anti-rheumatoid arthritis activities of epigallo-catechin-rich bioactive fraction from Camellia sinensis var. assamica, Assam variety white tea, and its comparative evaluation with green tea fraction.

  2022cites this paper
• Natural Polyphenols for Treatment of Colorectal Cancer

  2022cites this paper
• The Hallmarks of Flavonoids in Cancer

  2021cites this paper
• EGCG as Anti-Obesity and Anticancer Agent

  2021cites this paper
• “Skin cancer, polyphenols, and oxidative stress” or Counteraction of oxidative stress, inflammation, signal transduction pathways, and extracellular matrix remodeling that mediate skin carcinogenesis by polyphenols

  2021cites this paper
• Network medicine framework shows that proximity of polyphenol targets and disease proteins predicts therapeutic effects of polyphenols

  2021cites this paper
• A review on anti-cancer effect of green tea catechins

  2020cites this paper
• Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review

  2020cites this paper
• Mutations in transmembrane proteins: diseases, evolutionary insights, prediction and comparison with globular proteins

  2020cites this paper
• Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats

  2020cites this paper
• EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways

  2020cites this paper
• Tea bioactive components prevent carcinogenesis via anti‐pathogen, anti‐inflammation, and cell survival pathways

  2020cites this paper
• Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.

  2020cites this paper
• Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells.

  2020cites this paper
• Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer

  2020cites this paper
• Network Medicine Framework Shows Proximity of Polyphenol Targets and Disease Proteins is Predictive of the Therapeutic Effects of Polyphenols

  2020cites this paper
• Predicting the Health Impact of Dietary Polyphenols Using a Network Medicine Framework

  2020cites this paper
• Nutrition, Immunity, and Cancer

  2019cites this paper
• Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy

  2019cites this paper
• Selected Office Based Anticancer Treatment Strategies

  2019cites this paper
• The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer

  2019cites this paper
• Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors

  2019cites this paper
• Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review

  2018cites this paper
• Potential of Herbal Medicines in Colorectal Carcinoma and Their Mechanism of Action

  2018cites this paper
• Synergic Inhibition of Lung Carcinoma 95-D Cell Proliferation and Invasion by Combination with (−)-Epigallocatechin-3-Gallate and Ascorbic Acid

  2018cites this paper
• Integrative Treatment for Colorectal Cancer: A Comprehensive Approach

  2018cites this paper
• Possible Mechanisms of Green Tea and Its Constituents against Cancer

  2018cites this paper
• Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea

  2018cites this paper
• Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation

  2017cites this paper
• Green Tea Polyphenol, Epigallocatechin-3-Gallate (EGCG): Mechanisms and Application on Hepatocellular Carcinoma

  2017influential citation
• Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer

  2017cites this paper
• Phytochemicals - A Novel and Prominent Source of Anti-cancer Drugs Against Colorectal Cancer.

  2017cites this paper
• Antiangiogenic Effect of Flavonoids and Chalcones: An Update

  2017cites this paper
• Green Tea and Its Extracts in Cancer Prevention and Treatment

  2017cites this paper
• Modulation of binding to vascular endothelial growth factor and receptor by heparin derived oligosaccharide.

  2017cites this paper
• Morphometric abnormalities in spleen and kidney of the progeny of mice fed American cranberry extract (Vaccinium macrocarpon) during pregnancy and lactation.

  2017cites this paper
• New Chemotherapeutic Agents: Monoterpenes and Fatty Acid Synthase Inhibitors

  2016cites this paper
• Dendrimerized Magnetic Nanoparticles as Carriers for the Anticancer Compound, Epigallocatechin Gallate

  2016cites this paper
• The effects of green tea and pomegranate polyphenols on in vitro and in vivo VEGF activity

  2016cites this paper
• Urolithins, pomegranate ellagitannin microbial metabolites, as potential modulators of cell and molecular events associated with colorectal cancer: in vitro vs.: human studies= Potencial de las urolitinas, metabolitos microbianos derivados de los elagitaninos de la granada, como moduladores de proce

  2016cites this paper
• Cancer Preventive Activities of Tea Catechins

  2016cites this paper
• Catechins and Its Role in Chronic Diseases.

  2016cites this paper
• (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.

  2016cites this paper
• Drug Discovery from Mother Nature

  2016cites this paper
• Role of phytochemicals in the chemoprevention of tumors

  2016cites this paper
• Angioprevention in Colon Cancer from Bench to Bedside

  2015cites this paper
• Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.

  2015cites this paper
• Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG.

  2015cites this paper
• Dietary Phytochemicals as Cancer Preventive Agents: Efficacy andMechanisms

  2015cites this paper
• The effect of Greek herbal tea consumption on thyroid cancer: a case-control study.

  2015cites this paper
• Cancer Preventive Effects of Green Tea Polyphenols

  2014cites this paper
• Molecular mechanisms and physiology of disease

  2014cites this paper
• In vitro effects of prolonged exposure to quercetin and epigallocatechin gallate of the peripheral blood mononuclear cell membrane

  2014cites this paper
• Downstream carcinogenesis signaling pathways by green tea polyphenols: a translational perspective of chemoprevention and treatment for cancers.

  2014cites this paper
• (-)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer.

  2014cites this paper
• Methylated-(3′′)-Epigallocatechin Gallate Analog Suppresses Tumor Growth in Huh7 Hepatoma Cells Via Inhibition of Angiogenesis

  2014cites this paper
• Inhibition of VEGF Signaling by Polyphenols in Relation to Atherosclerosis and Cardiovascular Disease

  2014cites this paper
• Skin Cancer, Polyphenols, and Oxidative Stress

  2014cites this paper
• Epigenetic Mechanisms of Colon Cancer Prevention: What Can Nutrition Do?

  2014cites this paper
• EGCG Suppresses Melanoma Tumor Angiogenesis and Growth without Affecting Angiogenesis and VEGF Expression in the Heart and Skeletal Muscles in Mice

  2014cites this paper
• Inhibition of Angiogenesis in Cancer Management by Antioxidants: Ascorbate and P. leucotomos

  2014cites this paper
• An investigation into the anti-tumour properties and underlying mechanisms of natural polyphenols against ovarian cancer.

  2014influential citation
• Effects of Tea Catechins on Cancer Signaling Pathways.

  2014cites this paper
• Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer 71

  2013cites this paper
• Cancer Prevention with Green Tea Polyphenols

  2013cites this paper
• Effects of Green Tea Polyphenols under Hyperlipidemic Conditions through their Anti-Angiogenic Activity

  2013cites this paper
• Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.

  2013cites this paper
• Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate

  2013cites this paper
• Effect of Green Tea Extract on Hepatocellular Carcinoma

  2013cites this paper
• Nutrigenomics and Proteomics of Tea Polyphenols

  2013cites this paper
• Molecular Aspects of Cancer Prevention by Green Tea

  2013cites this paper
• Efectos del té verde sobre el riesgo de cáncer de mama

  2013cites this paper
• (−)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α

  2013cites this paper
• Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2.

  2013cites this paper
• Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling

  2013cites this paper
• EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression

  2013cites this paper
• Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives.

  2013cites this paper
• PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.

  2013cites this paper